Orange Book product · Brand (NDA)
FARYDAK
PANOBINOSTAT LACTATE
Brand (NDA)NDA 205353DISCN SECURA
At a glance
Feb 23, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 23, 2015
11 yr 6 mo ago
Today
Patent 7989494 expires
Listed drug substance patent expiration.
Jan 17, 2028
in 1 yr 7 mo
Patent 8883842 expires
Listed method-of-use patent (U-1669) expiration.
Jun 13, 2028
in 2 yr
Pharmaceutical detail
Active ingredient
PANOBINOSTAT LACTATE
Strength
EQ 15MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 205353
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7989494 | Jan 17, 2028 | in 1 yr 7 mo | SubstanceProduct |
| 8883842 | Jun 13, 2028 | in 2 yr | U-1669 |
